Head and Neck Neoplasms

The grounding supports multifactorial oncogenesis rather than a single cause. Reported contributors include persistent exposure to tobacco, alcohol, betel quid, and human papillomavirus in oral squamous cell carcinoma, along with genetic alteration and epigenetic modification. The literature also emphasizes that the disease is genetically complex and influenced by the tumor microenvironment.

The disease is characterized by complex genetic changes and dysregulated interactions between tumor cells and the surrounding microenvironment. Reviews describe immune evasion, altered self-immunogenicity, and expression of immunosuppressive mediators as key processes that support angiogenesis, proliferation, and metastasis. Tumor-infiltrating lymphocytes and immune checkpoint pathways such as PD-1/PD-L1 are highlighted as important components of the immune biology of head and neck cancers.

Persistent exposure to tobacco, alcohol, betel quid, and human papillomavirus is identified as increasing risk for oral squamous cell carcinoma. The literature also links oral potentially malignant disorders with increased risk of progression to oral squamous cell carcinoma. Broader head and neck cancer reviews emphasize the role of a dysregulated tumor microenvironment and underlying genetic complexity, but do not specify additional risk factors in the supplied grounding.

For most patients, surgery and radiotherapy are described as the primary treatment modalities. Chemotherapy is used in curative locoregional treatment, with concomitant chemotherapy improving overall survival in non-metastatic head and neck cancer in the cited meta-analysis. The grounding also supports immunotherapy approaches, especially immune checkpoint inhibitors targeting PD-1/PD-L1 pathways, as well as ongoing use of conventional cytotoxic chemotherapy and regional surgery.